Left Atrial Appendage Closure: Prevention and Management of Periprocedural and Postprocedural Complications

Area of Science:

• Cardiology
• Medical Devices
• Interventional Procedures

Background:

• Left atrial appendage closure (LAAC) offers an alternative to oral anticoagulants for stroke risk reduction in nonvalvular atrial fibrillation (NVAF).
• LAAC is primarily indicated for patients intolerant to oral anticoagulants, who often present with significant comorbidities.
• Minimizing procedural complications is crucial for this patient group.

Purpose of the Study:

• To review the periprocedural and postprocedural complications associated with LAAC.
• To discuss strategies for the prevention and management of these LAAC-related complications.

Main Methods:

• Literature review of LAAC procedures and complication data.
• Analysis of common complications including vascular access issues, device embolization, and pericardial effusion.
• Discussion of specific adverse events such as stroke, air embolus, and device-related issues.

Main Results:

• LAAC demonstrates noninferiority to vitamin K antagonists in reducing stroke risk for NVAF.
• Complications can occur during or after the procedure, requiring careful monitoring and management.
• Key complications discussed include vascular access problems, pericardial effusion, device embolization, stroke, and device-related issues like leaks or thrombus.

Conclusions:

• LAAC is a viable alternative for stroke prevention in NVAF patients, particularly those with contraindications to anticoagulation.
• Effective management of periprocedural and postprocedural complications is essential for patient safety and successful outcomes.
• Understanding and addressing potential complications like pericardial effusion, device embolization, and stroke is critical for widespread LAAC adoption.